✦ LIBER ✦

A viral kinetic study using pegylated interferon alpha 2b and lamivudine in naive patients with HBeAg(−)/I-BV-DNA(+) chronic hepatitis B: preliminary results

✍ Scribed by Vana Sypsa; Nicolaos C. Tassopoulos; Dimitrios Chrysagis; Konstantinos Mimidis; Themistoklis Vassiliadis; Maria Raptopoulou; Ioannis Ketikoglou; Caterina Haida; Dimitris Paraskevis; Francois Lafleur; Angelos Hatzakis

Book ID: 118565246
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 116 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80330-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A viral kinetic study using pegylated in

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

✍ Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(؊) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap

Comparative analysis of Peg-interferon a

Comparative analysis of Peg-interferon alpha-2b and lamivudine in the treatment of chronic hepatitis B patients: preliminary results

✍ D. Koliouskas; I. Sidiropoulos; M. Masmanidou; S. Dokas; A. Ziakas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 220 KB

51 Early hepatitis B viral dynamics and

51 Early hepatitis B viral dynamics and end of treatment virological response (ETVR) in chronic hepatitis B/ HBeAg (−) patients receiving 1528 0689V 2 pegylated interferon alpha-2b and/or lamivudine

✍ T. Vassiliadis; V. Sypsa; K. Mimidis; N.C. Tassopoulos; D. Chrysagis; I. Ketikog 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Effective prediction of outcome of combi

Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices

✍ Hideyuki Nomura; Yugo Miyagi; Hironori Tanimoto; Masashi Higashi; Hiromi Ishibas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 391 KB

A viral kinetic study using pegylated in

A viral kinetic study using pegylated interferon alpha 2B and lamivudine in naive patients with hepatitis B E antigen negative/hepatitis B virus DNA-positive chronic hepatitis B: Vana Sypsa Mrs, Athens Univ Medical Sch, Athens Greece; Nicolaos C Tassopoulos Mr, Western Attica General Hospital, Athens Greece; Dimitris Chrysagis Mr, Loimodon Hospital, Thessaloniki Greece; Maria Raptopoulou Mrs, Aristoteleion Univ of Thessaloniki, Thessaloniki Greece; Ioannis Ketikoglou Mr, Hippokration General Hospital, Athens Greece; Themistoklis Vassiliadis Mr, Hippokration General Hospital, Thessaloniki Greece; Catherina Haida Mrs, Dimitris Paraskevis Mr, Athens Univ Medical Sch, Athens Greece; Francois Lafleur Mr, Schering Plough, Kenilworth, NJ; Angelos Hatzakis Mr, Athens Univ Medical Sch, Athens Greece

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB